March 23, 2025

cmerp

3)
3 min read

3)

cmerp January 12, 2022
3). whose delivery was reduced by anti-CLU antibody less than apolipoprotein-enhanced and regular conditions. Coimmunoprecipitation revealed a...
Read More
Improving Malignancy Chemotherapy Performance by Blocking LPA-Mediated Inflammatory Signaling Given the considerable overlap between fibrotic and carcinoma pathways [136], LPA signaling inhibitors are expected to serve as useful adjuncts in cancer therapy, largely by mitigating the loss of efficacy for chemotherapy and radiotherapy via blockage of the pro-survival benefits of tumor-promoting inflammation
3 min read

Improving Malignancy Chemotherapy Performance by Blocking LPA-Mediated Inflammatory Signaling Given the considerable overlap between fibrotic and carcinoma pathways [136], LPA signaling inhibitors are expected to serve as useful adjuncts in cancer therapy, largely by mitigating the loss of efficacy for chemotherapy and radiotherapy via blockage of the pro-survival benefits of tumor-promoting inflammation

cmerp January 9, 2022
Improving Malignancy Chemotherapy Performance by Blocking LPA-Mediated Inflammatory Signaling Given the considerable overlap between fibrotic and carcinoma...
Read More
Similarly, compound 6 protected against the LRRK2:G2019SCinduced decreases in MMP in a dose dependent manner where 10 M compound 6 returned MMP dissipation to untreated levels (Figure 6B)
3 min read

Similarly, compound 6 protected against the LRRK2:G2019SCinduced decreases in MMP in a dose dependent manner where 10 M compound 6 returned MMP dissipation to untreated levels (Figure 6B)

cmerp January 7, 2022
Similarly, compound 6 protected against the LRRK2:G2019SCinduced decreases in MMP in a dose dependent manner where 10...
Read More

You may have missed

Proteins scaffold antigens carrying the V1V2 locations from HIV-1 subtypes A, B, C, CRF01_AE or D were assayed in pilot research, and 6 were selected to assess cross-reactive Stomach muscles in the plasma from the initial RV144 case-control cohort (41 infected vaccinees, 205 frequency-matched uninfected vaccinees, and 40 placebo recipients) using ELISA and a binding Stomach multiplex assay
3 min read

Proteins scaffold antigens carrying the V1V2 locations from HIV-1 subtypes A, B, C, CRF01_AE or D were assayed in pilot research, and 6 were selected to assess cross-reactive Stomach muscles in the plasma from the initial RV144 case-control cohort (41 infected vaccinees, 205 frequency-matched uninfected vaccinees, and 40 placebo recipients) using ELISA and a binding Stomach multiplex assay

March 3, 2025
But when analyzing the 5 different proteins (LTAg, stAg, VP1, VP2, and agnoprotein) that were present as peptides around the microarray, it was surprising to see that antibody responses to stAg peptide were significantly elevated (p?=?3
3 min read

But when analyzing the 5 different proteins (LTAg, stAg, VP1, VP2, and agnoprotein) that were present as peptides around the microarray, it was surprising to see that antibody responses to stAg peptide were significantly elevated (p?=?3

March 2, 2025
One efficient method is replica-exchange molecular dynamics simulation (Sugita and Okamoto 1999)
3 min read

One efficient method is replica-exchange molecular dynamics simulation (Sugita and Okamoto 1999)

March 1, 2025
This work was supported partly with a Marie Curie Development Host Fellowship (HPMD-CT-2000-00034, to M
2 min read

This work was supported partly with a Marie Curie Development Host Fellowship (HPMD-CT-2000-00034, to M

February 28, 2025